Back
Alimera Sciences Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
93
ALIM
Alimera Sciences
Last Price:
5.53
Seasonality Move:
-11.98%
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
151.67
Seasonality Move:
21.71%
Buy
93
Alimera Sciences (ALIM)
is a Buy
Is Alimera Sciences a Buy, Sell or Hold?
- The current Alimera Sciences [ALIM] share price is $5.55. The Score for ALIM is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.
- ALIM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $151.73. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALIM Stock Price Chart
What is Alimera Sciences's stock price today?
-
The Alimera Sciences share price today is $5.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALIM is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $151.73
The current trend is moderately bullish and SRPT is experiencing slight selling pressure.
ALIM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.65 | Buy |
Relative Strength Index (14 RSI): | 82.73 | Buy |
Chaikin Money Flow: | 282336 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.76 - 5.14) | Buy |
Bollinger Bands (100): | (3.03 - 4.35) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.22 | Buy |
Relative Strength Index (14 RSI): | 61.51 | Buy |
Chaikin Money Flow: | -40120 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (118.42 - 153.54) | Buy |
Bollinger Bands (100): | (118.38 - 140.08) | Buy |
ALIM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.53 | Buy |
20-day SMA: | 4.17 | Buy |
50-day SMA: | 3.66 | Buy |
200-day SMA: | 3.6 | Buy |
8-day EMA: | 5.28 | Buy |
20-day EMA: | 4.55 | Buy |
50-day EMA: | 3.96 | Buy |
200-day EMA: | 3.63 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 155.81 | Sell |
20-day SMA: | 139.08 | Buy |
50-day SMA: | 132.55 | Buy |
200-day SMA: | 116.53 | Buy |
8-day EMA: | 152.29 | Sell |
20-day EMA: | 143.85 | Buy |
50-day EMA: | 134.87 | Buy |
200-day EMA: | 122.68 | Buy |
Alimera Sciences Earnings Growth & ALIM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.04 per share, an increase this year of $0.24 per share, and an increase next year of $0.24 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Alimera Sciences Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |